Free Trial

Invictus Private Wealth LLC Sells 72,000 Shares of UiPath, Inc. (NYSE:PATH)

UiPath logo with Computer and Technology background

Key Points

  • Invictus Private Wealth LLC significantly reduced its stake in UiPath, Inc. by 77.4%, selling 72,000 shares and leaving them with 21,000 shares worth approximately $216,000.
  • Several institutional investors, like Tidal Investments and True Wealth Design, increased their stakes in UiPath during the last quarter, highlighting a mixed sentiment among institutional holders.
  • UiPath reported a surprising revenue increase of 6.4% to $356.62 million for the quarter, surpassing analysts' expectations and achieving an EPS of $0.11 against an anticipated $0.10.
  • Want stock alerts on UiPath? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Invictus Private Wealth LLC decreased its stake in UiPath, Inc. (NYSE:PATH - Free Report) by 77.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,000 shares of the company's stock after selling 72,000 shares during the quarter. Invictus Private Wealth LLC's holdings in UiPath were worth $216,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of PATH. XTX Topco Ltd acquired a new stake in UiPath in the first quarter valued at $545,000. Federated Hermes Inc. boosted its holdings in UiPath by 479.3% in the 1st quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company's stock valued at $58,917,000 after purchasing an additional 4,732,712 shares in the last quarter. Meeder Advisory Services Inc. purchased a new stake in UiPath in the 1st quarter valued at approximately $105,000. MRP Capital Investments LLC purchased a new stake in shares of UiPath during the 1st quarter worth approximately $82,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of UiPath by 6.3% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 135,922 shares of the company's stock worth $1,400,000 after acquiring an additional 8,088 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.

Insider Activity

In related news, CFO Ashim Gupta sold 56,322 shares of UiPath stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $12.72, for a total transaction of $716,415.84. Following the completion of the transaction, the chief financial officer directly owned 859,991 shares of the company's stock, valued at $10,939,085.52. This trade represents a 6.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $12.43, for a total transaction of $559,350.00. Following the transaction, the chief executive officer directly owned 5,058,376 shares of the company's stock, valued at $62,875,613.68. This represents a 0.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 831,310 shares of company stock valued at $10,428,922 over the last three months. 23.19% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PATH. Royal Bank Of Canada lifted their price objective on UiPath from $13.00 to $15.00 and gave the stock a "sector perform" rating in a research report on Friday, May 30th. BMO Capital Markets boosted their price target on UiPath from $11.50 to $15.50 and gave the company a "market perform" rating in a report on Friday, May 30th. Truist Financial boosted their price target on UiPath from $12.00 to $13.00 and gave the company a "hold" rating in a report on Friday, May 30th. Wall Street Zen downgraded UiPath from a "strong-buy" rating to a "buy" rating in a report on Sunday. Finally, Barclays reiterated an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, UiPath presently has a consensus rating of "Hold" and an average price target of $13.83.

Get Our Latest Stock Report on UiPath

UiPath Trading Down 0.7%

PATH traded down $0.08 during trading on Tuesday, hitting $11.27. The stock had a trading volume of 4,809,355 shares, compared to its average volume of 11,794,078. The firm has a market cap of $6.03 billion, a PE ratio of -94.03, a P/E/G ratio of 14.55 and a beta of 1.03. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $15.93. The company has a 50 day simple moving average of $12.61 and a 200-day simple moving average of $12.35.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The company had revenue of $356.62 million for the quarter, compared to analyst estimates of $332.17 million. During the same period last year, the business posted $0.13 EPS. The business's quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines